European Heart Journal Acceptance Rate

The ESC does not publish a stable official acceptance rate for European Heart Journal. The journal's ESC page reports the impact factor and editorial board but omits acceptance-rate data.

Third-party aggregators report estimates in the 10-15% range. Those estimates are directionally useful - this is clearly among the most selective cardiology journals in the world - but the specific numbers vary by source and year and should not be treated as precise.

What is stable is the editorial posture:

• the journal publishes 48 issues per year, enabling rapid turnaround for consequential work
• large multicenter trials, registry analyses, and guideline-shaping evidence are prioritized
• the editorial team screens hard for clinical scale and generalizability
• EHJ publications frequently inform ESC clinical practice guidelines

That combination of high volume and high selectivity means the journal can afford to be demanding about both quality and impact.

At triage, the editor is usually asking:

• is this study large enough and well-designed enough to influence clinical practice?
• does the work address a question relevant to current or upcoming ESC guidelines?
• is the patient population generalizable beyond a single center or country?
• would the findings change how cardiologists manage a specific condition?

Papers that address the first question with a large, well-characterized multicenter cohort or randomized trial will survive triage at much higher rates than single-center observational studies, regardless of how well-written they are.

For European Heart Journal, the useful question is:

Is this study large-scale and consequential enough that ESC guideline committees would want to see it?

If yes, the journal is a strong fit. If the paper is methodologically sound but limited to a single center, a small cohort, or a question that does not clearly connect to guideline-level decisions, the acceptance rate is not the constraint. The clinical significance is.

The common misses are:

• centering strategy around an unofficial percentage instead of checking clinical scale
• submitting single-center studies with fewer than 500 patients for common conditions
• presenting biomarker or imaging findings without connecting them to clinical outcomes
• treating EHJ as a European alternative to Circulation without understanding the ESC guideline connection
• ignoring the ESC journal cascade - EHJ has companion journals (EHJ Open, EHJ - Quality of Care) that absorb sound work below the flagship bar

Those are scale and impact problems before they are rate problems.

If you are deciding whether to submit, these pages are more useful than an unofficial rate:

• European Heart Journal cover letter
• European Heart Journal review time
• European Heart Journal submission process
• Circulation acceptance rate (the AHA flagship alternative)

Together, they tell you whether the paper has enough clinical scale, whether the editorial timeline is manageable, and whether a different cardiology venue would be a cleaner first submission.

In our pre-submission review work evaluating manuscripts targeting European Heart Journal, three patterns generate the most consistent desk rejections. Each reflects the journal's standard: large-scale cardiovascular research with guideline-level clinical evidence and broad relevance to the European and international cardiology community.

Single-center observational study without statistical power for guideline evidence. EHJ's editorial philosophy centers on studies that can influence ESC clinical practice guidelines. The failure pattern is a well-conducted observational study at one academic cardiology center reporting an association between a new biomarker, imaging parameter, or treatment approach and cardiovascular outcomes, with 200-500 patients, statistically significant results, and a clear hypothesis. The problem is not the science: it is that guideline committees require replication, population generalizability, and effect sizes that a single-center study cannot provide. EHJ editors apply a specific test: would a guideline writing committee find this sufficient to change a recommendation? For observational studies, the answer almost always requires multicenter data. Papers that fail this test are redirected to EHJ Open, Heart, or ESC subspecialty titles rather than desk-rejected outright.

Biomarker or imaging study reporting associations without hard clinical outcomes. EHJ prioritizes studies that connect measurements to practice decisions. The failure pattern is a paper reporting that a new plasma biomarker, echocardiographic parameter, or cardiac MRI measurement is elevated in patients with a specific cardiovascular phenotype, correlates with established biomarkers, or predicts a surrogate marker. A paper showing that a new protein is elevated in patients with HFpEF compared to controls, that a new strain parameter correlates with BNP in a heart failure cohort, or that a cardiac MRI finding is associated with reduced exercise capacity, generates hypothesis without clinical decision-making evidence. EHJ expects the paper to answer: what does a cardiologist do differently if they measure this? Without a hard endpoint, the answer is unclear, and the paper belongs in a research-oriented journal rather than a clinical practice flagship.

Study limited to a single cardiovascular subspecialty without broader cardiovascular relevance. EHJ's readership is general cardiologists, not subspecialists. The failure pattern is a paper reporting excellent work in one area of cardiology that would primarily be read and applied by one subspecialist group: a new ablation technique for a specific arrhythmia subset, a new device approach for a specific structural heart disease anatomy, or a treatment optimization study for a narrow heart failure phenotype. These papers may be strong science and appropriate for EHJ-EP, EHJ-Cardiovascular Interventions, or EHJ-Heart Failure, but the flagship audience test fails. EHJ editors redirect them to the appropriate subspecialty title rather than asking authors to artificially broaden the framing. A European Heart Journal submission readiness check can assess whether the clinical scale and breadth of relevance meet EHJ's threshold before submission.

The honest answer to "what is the European Heart Journal acceptance rate?" is that the ESC does not publish one, and third-party estimates in the 10-15% range should be treated as approximate.

The useful answer is:

• yes, this is among the most selective cardiology journals in the world
• no, a guessed percentage is not the right planning tool
• use clinical scale, ESC guideline relevance, and patient-population generalizability as the real filter instead

If you want help pressure-testing whether this manuscript is positioned for an EHJ submission before upload, a European Heart Journal submission readiness check is the best next step.

The acceptance rate for European Heart Journal does not distinguish between desk rejections and post-review rejections. A paper desk-rejected in 2 weeks and a paper rejected after 4 months of review both count the same. The rate also does not reveal how acceptance varies by article type, geographic origin, or research area within the journal's scope.

Acceptance rates cannot predict your individual odds. A strong paper with clear scope fit, complete data, and solid methodology has substantially better odds than the headline number suggests. A weak paper with methodology gaps will be rejected regardless of the journal's overall rate.

A European Heart Journal submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.